Apellis Pharmaceuticals
APLS
APLS
210 hedge funds and large institutions have $4.55B invested in Apellis Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 53 funds opening new positions, 73 increasing their positions, 62 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
210
Holders Change
+27
Holders Change %
+14.75%
% of All Funds
3.32%
Holding in Top 10
11
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+37.5%
% of All Funds
0.17%
New
53
Increased
73
Reduced
62
Closed
23
Calls
$82.1M
Puts
$82.8M
Net Calls
-$722K
Net Calls Change
-$19.3M
Top Buyers
Top Sellers
| 1 |
RI
1
RTW Investments
New York
|
$2.6M |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$21.8M |
| 3 |
3
JPMorgan Chase & Co
New York
|
$64.3M |
| 4 |
DM
4
Deerfield Management
New York
|
$0 |
| 5 |
TLP
5
Tri Locum Partners
New York
|
$0 |
